![]() ![]() The risk of urgency (adjusted RR = 1.94 95% CI 1.15–3.29) and hesitancy (adjusted RR = 1.78 95% CI 1.03–4.19) was greater for women who reported taking medication for constipation at both time points. Women (mean age 43.3 years, standard deviation 0.5), who took medication for constipation at either time point had increased risks of urgency (adjusted relative risks = 1.35 95% confidence interval 1.04–1.95) and hesitancy (adjusted RR = 1.72 95% CI 1.04–3.01) compared with women who reported not using medication for constipation at either time point. Results: At follow-up, the prevalence of any LUTS was 40%. ![]() LUTS were considered present if symptoms were reported to occur at least “sometimes” for all subtypes, except for increased daytime frequency (≥9 times) and nocturia (≥2 times nightly). LUTS were categorized according to International Continence Society definitions as stress urinary incontinence (UI), urgency UI, mixed UI, nocturia, increased daytime frequency, urgency, hesitancy, and intermittency. After 10 years of follow-up, women provided self-reports of LUTS using an adapted version of the International Consultation on Incontinence Questionnaire on Female LUTS. Women with LUTS at baseline were excluded. Materials and Methods: The study uses data from 3,729 women from the Avon Longitudinal Study of Parents and Children who provided self-reports of medication intake for constipation at two time points (Baseline): 2001–20–2005. ![]() Objective: To examine the prospective association between constipation and risk of developing lower urinary tract symptoms (LUTS) in parous middle-aged women. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |